Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Woodline Partners
AddedFeb 13, 2024
UpdatedJun 28, 2026
Woodline Partners

Woodline Partners

Operating

San Francisco-based Woodline Partners LP is a private equity firm specializing in global Health Care and Technology sectors.

Founded
2018
Firm
Compare
Portfolio
Employees
Website

Woodline Partners is a San Francisco-based investment firm specializing in global Health Care and Technology sectors. The firm implements a fundamental sub-sector equity strategy, focusing on North American, European, and Asian markets. Woodline's approach emphasizes bottom-up analysis and leverages an established network of corporate executive and industry relationships.

The firm's portfolio includes notable companies such as Amylyx Pharmaceuticals, ElevateBio, Odyssey Therapeutics, and Patreon. Woodline Partners typically invests in Series B and later stages, including post-IPO equity rounds. Their investment strategy aims to hedge unpredictable factors and focus on company-specific details to assess long-term potential.

Woodline Partners - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments25
Current Portfolio Count20
Total Portfolio Exits2

Top Investment Stages

Series B9 (40.9%)
Post Ipo Equity7 (31.8%)
Series C3 (13.6%)
Series A2 (9.1%)
Private Equity1 (4.5%)

Stage Mix

Series B 41%Post Ipo Equity 32%Series C 14%Series A 9%Private Equity 5%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Cuprum Metals logo

Cuprum Metals

Outlook Therapeutics logo

Outlook Therapeutics

Odyssey Therapeutics logo

Odyssey Therapeutics

Soleno Therapeutics logo

Soleno Therapeutics

Septerna logo

Septerna

Immunome logo

Immunome

Lyra Therapeutics logo

Lyra Therapeutics

ElevateBio logo

ElevateBio

Maze Therapeutics logo

Maze Therapeutics

Arbor Biotechnologies logo

Arbor Biotechnologies

Cedilla Therapeutics logo

Cedilla Therapeutics

Tango Therapeutics logo

Tango Therapeutics

Amylyx Pharmaceuticals logo

Amylyx Pharmaceuticals

Frontier Medicines logo

Frontier Medicines

Kriya Therapeutics logo

Kriya Therapeutics

Talkspace logo

Talkspace

NeoGenomics Laboratories logo

NeoGenomics Laboratories

Affinia Therapeutics logo

Affinia Therapeutics

Patreon logo

Patreon

Vividion Therapeutics logo

Vividion Therapeutics

Scorpion Therapeutics logo

Scorpion Therapeutics

Kronos Bio logo

Kronos Bio

Woodline Partners - Similar Investment Firms

Woodford Investment Management logo

Woodford Investment Management

woodfordfunds.com

Old Line Capital Partners logo

Old Line Capital Partners

oldlinecap.com

SightLine Partners logo

SightLine Partners

Wolfswood partners logo

Wolfswood partners

Timberline Management logo

Timberline Management

Orangewood Partners logo

Orangewood Partners

Woodland Capital logo

Woodland Capital

Woodside Fund logo

Woodside Fund

Redline Capital logo

Redline Capital

Chartline Capital Management logo

Chartline Capital Management

chartline.com

Timberline Venture Partners logo

Timberline Venture Partners

Riverwood Capital logo

Riverwood Capital

Waypoint Capital Partners logo

Waypoint Capital Partners

Waterline Ventures logo

Waterline Ventures

Kline Hill Partners logo

Kline Hill Partners

klinehill.com

Woodline Partners - Classification

Also Known As
  • Woodline Partners Ltd.
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end
Show 5 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified